|Articles|March 18, 2020
Three Key Critical Considerations Before Embarking on Decentralized Trials
Author(s)Oracle
- Clinical trials can be designed across a continuum of formats. - Adding decentralized elements to trials can help acquire high-quality data. - Sponsors must understand the impact across the trial landscape for success.
Newsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Related Content
Trending on PharmExec
1
FDA Approves Yuvezzi to Treat Presbyopia in Adults
2
Public Citizen Files Suit Against Trump Administration for Undisclosed Details of Pfizer and Eli Lilly Drug-Pricing Deals: Report
3
Insilico Medicine Enters $120 Million Drug Development Collaboration with Qilu Pharmaceuticals to Advance Cardiometabolic Therapies
4
Pharma and MedTech Rarely Collide. That Might Be the Biggest Miss in Healthcare
5